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Aim.Toidentifyandsystematicallyreviewtheclinimetricpropertiesofhabitualphysicalactivity(HPA)measuresinyoungchildren
with a motor disability. Method. Five databases were searched for measures of HPA including: children aged <6.0 years with a
neuromuscular disorder, physical activity deﬁned as “bodily movement produced by skeletal muscles causing caloric expenditure”,
reported HPA as duration, frequency, intensity, mode or energy expenditure, and evaluated clinimetric properties. The quality of
papers was assessed using the COSMIN-checklist. A targeted search of identiﬁed measures found additional studies of typically
developing young children (TDC). Results. Seven papers assessing four activity monitors met inclusion criteria. Four studies
were of good methodological quality. The Minimod had good ability to measure continuous walking but the demonstrated
poor ability to measure steps during free-living activities. The Intelligent Device for Energy Expenditure and Activity and
Ambulatory Monitoring Pod showed poor ability to measure activity during both continuous walking and free-living activities.
The StepWatch showed good ability to measure steps during continuous walking in TDC. Interpretation. Studies assessing the
clinimetric properties of measures of HPA in this population are urgently needed to allow assessment of the relationship between
HPA and health outcomes in this group.
1.Introduction
Habitual physical activity (HPA) is an established deter-
minant of health in children and is required for healthy
development,includingthegrowthofboneandmusclemass,
improved balance and motor skills, maintaining a healthy
weight and improved psychological wellbeing [1, 2]. Limited
evidence suggests young children with motor disorders are
lessphysicallyactivethantheirtypicallydevelopingpeers[3].
Consequently they may be at risk of suboptimal growth and
development in addition to the development of secondary
conditions such as chronic pain, fatigue, and low bone
density which can lead to diminished bone health [4, 5].
Australian physical activity guidelines state children aged
from one to ﬁve years should be physically active for three
hours throughout the day and should not be sedentary,
restrained,orkeptinactive,formorethanonehouratatime,
with the exception of sleeping [2]. Studies investigating the
link between HPA and health outcomes for children with
motor impairments have not been conducted. These studies
are urgently needed to (i) determine the HPA patterns and
intensities of children with motor disabilities, (ii) support
the importance of physical activity promotion and inactivity
prevention, (iii) determine the dose-response relationship2 International Journal of Pediatrics
betweenphysicalactivityandhealthoutcomes,and(iv)allow
assessment of the eﬀectiveness of interventions aimed at
increasing HPA.
Physical activity is deﬁned as “any bodily movements
usingskeletalmusclesthatresultsinenergyexpenditure”[6].
The International Classiﬁcation of Functioning, Disability
and Health (ICF) further divides physical activity into the
concepts of “performance” and “capacity” [7]. Performance
is deﬁned as the execution of an activity in the natural
environment. This is distinct from capacity which refers to
a child’s maximal ability to perform an activity in an ideal
or standardised environment. Performance and capacity
to complete a task (e.g., jumping) can be determined by
observing the child undertake that speciﬁc task within a
limited time frame in their natural and ideal environment,
respectively. HPA, on the other hand, describes a child’s
typical daily activity pattern and hence includes their
performance of a multitude of activities which necessitates
measurement across multiple days [8]. The variables of
frequency(howoftenachilddoesanactivity),intensity(how
hard a child works to do the activity), duration (how long a
child does an activity), and mode (what the child is doing)
are used to characterise HPA patterns, while activity-related
energy expenditure (AEE) is used as a summary variable of
all the other indicators [9, 10].
Direct observation is considered the gold standard for
physical activity classiﬁcation, while doubly labelled water in
combination with resting energy expenditure is considered
the gold standards for calculating AEE [10]. Measures of
HPA include both objective and subjective methods [11].
Objective measures include heart rate monitors, accelerom-
eters, and pedometers. Subjective methods include self- or
proxy reports, interviews, and diaries. The measurement of
HPA in typically developing children (TDC) has received a
great deal of attention in the last decade, primarily due to a
concern over the increasing rate of overweight and obesity
in childhood [12]. A systematic review of pedometers and
accelerometers has identiﬁed moderate-to-good evidence of
validity and strong evidence of reliability for the ActiGraph
accelerometer in preschool-aged TDC [13]. Children with
motor impairments may not be walking but instead cruising,
crawling, bottom shuﬄing, rolling, use walking aids or a
wheelchair as means of locomotion, and those who are
walking may have diﬀerent gait patterns and speed of
movement than TDC [14]. This variation in movement
patterns necessitates validation of motion sensors speciﬁcally
for this population.
Systematic reviews of measures of physical activity in
children and adolescents with cerebral palsy (CP) have been
conducted [15, 16]. Capio et al. [15] included children with
CP from birth to 18 years and concluded that the subjec-
tive measures of the Activities Scale for Kids-Performance
Version (ASKp) and the Children’s Assessment of Partici-
pation and Enjoyment (CAPE) are the only measures with
established validity and reliability in children with physical
disabilities from the age of six years. The review by Clanchy
et al. [16] included children with CP aged 10–18 years
and identiﬁed the CAPE as the measure with the strongest
evidence of reliability and validity. It was also noted that no
measures have been assessed in children with more severe
disability who are wheelchair dependent. This paper did
not include the ASKp as it did not meet inclusion criteria
of 60% of items relating to a domain of physical activity
performance.This was done to ensure the included measures
assess physical activity as traditionally deﬁned by Caspersen
et al. [6] and not “participation” which does not take into
consideration the sedentary or active nature of the activity.
Both reviews note the lack of HPA measures which can
assess activity intensity, which limits their ability to provide
meaningful comparison with physical activity guidelines, as
children from the age of six years are advised to accumulate
60 minutes of moderate-to-vigorous physical activity every
day[17].Thiscurrentpaperaimstosystematicallyreviewthe
clinimetric properties (validity, reproducibility, and clinical
utility) of measures of HPA in children less than 6 years of
age with a motor disability [6].
2. Method
2.1. Search Strategy. A systematic literature search was per-
formed by one reviewer (SO) of the electronic bibliographic
databases PubMed, CINAHL, EMBASE, SPORTDiscus, and
Web of Science from their inception to September, 2011.
Databases were searched using medical subject headings
(MeSH) terms and text words for physical activity and
disability, limiting the search to the age group <6.0 years.
2.2. Inclusion and Exclusion Criteria. Measures of HPA were
included which met the following criteria: (i) included
children less than six years of age with a motor disability
caused by neuromuscular disorders; (ii) deﬁned physical
activity as any bodily movement produced by skeletal
muscles that results in caloric expenditure [6]; (iii) reported
physical activity in terms of duration, frequency, intensity,
or energy expenditure; (iv) questionnaires where at least
60% of items related to a domain of HPA; (v) evaluated
clinimetric properties for the measurement of HPA. Studies
wereexcludediftheywere(i)notpublishedinEnglish,dueto
lack of translation services; (ii) primarily measured capacity
or participation.
The title and abstract of all retrieved references were
screened by the ﬁrst author to exclude any papers which did
not include children in the target age group or were not on
the topic of physical activity measures. A second screening
of abstracts was performed by two authors (SO, LM)
independently to exclude those that did not include habitual
physical activity measures but rather assessed capacity or
participation measures. For the remaining abstracts, full
papers were retrieved and screened by two authors (SO,
LM). Publications which did not assess the clinimetric
properties of measures of HPA in children with motor
disabilities were excluded. Upon disagreement between the
tworeviewers,athirdreviewer(KB)reviewedthepublication
in question. The reference lists of included papers and
relevant reviews were screened, and electronic author and
citation tracking were performed when available, to identify
relevant publications not identiﬁed by the initial search
strategy. For measures where clinimetric properties wereInternational Journal of Pediatrics 3
found in children less than six years of age with a motor
disability,afurthersearchidentiﬁedanyevidenceintypically
developing children in the same age group.
2.3. Data Extraction and Quality Review. The COSMIN
(COnsensus-basedStandardsfortheselectionofhealthMea-
surement INstruments) checklist [18] was used to rate the
methodological quality of the study designs used to evaluate
the clinimetric properties validity and reproducibility for
measures of HPA. The COSMIN was developed through
an international Delphi study to assess the methodological
quality of studies on measurement properties of health-
relatedpatient-reportedoutcomes(HR-PROs)[18];however
themeasurementpropertiesarealsorelevanttootherhealth-
related measurement instruments. The scoring system was
developed based on expert discussion and testing on 46
articles identiﬁed by a systematic review and uses a “worst
score counts” algorithm [19]. Each item within a speciﬁc
measurement property is rated individually as “excellent”
(+++), “good” (++), “fair” (+), or “poor” (−)a n da n
overall score is given by taking the lowest score of any
of the items within the assessment of the measurement
property. Measurement properties included in this paper
were measurement error (COSMIN box C), hypothesis
testing (COSMIN box F), and criterion validity (COSMIN
box H). The methodological quality rating of the papers was
separated into study design and statistical analysis.
2.4. Rating of Study Design. The study design for the
assessment of measurement properties was rated as having
“excellent” quality if all relevant items within a given
checklist scored “excellent.” Study design was rated as “good”
ifinformationforsomeitemswasnotcompleteandtherefore
could not be scored “excellent,” though it could be assumed
thesewereof“good” quality.A“fair”qualityratingwasgiven
if there were minor ﬂaws in the design. If the results were not
to be trusted because of major ﬂaws in the design, a study is
rated as “poor” [19]. To assess if there were any important
ﬂaws in the design or methods of the study (COSMIN Box
H, item ﬁve), items from the systematic review of activity
monitors in TDC were used [13] as a guide in addition
to whether or not the testing protocol included free-living
activities.
One modiﬁcation was made to the original COSMIN
checklist. Proposed sample size requirements [20]w e r e
applied in the clinimetric properties section instead of the
study design section. The decision to separate study design
and sample size requirements was made as sample size does
notdeterminestudydesignqualityassuchbutdoesaﬀectthe
statistical power available to detect a signiﬁcant result.
2.5. Statistical Methods and Clinimetric Properties of HPA
Measures. For the assessment of criterion validity, the
COSMIN checklist accepts correlations or the area under
the receiver operator characteristic (AUC-ROC) curve as
“excellent” statistical methods for continuous measures [19].
For dichotomous scales sensitivity and speciﬁcity calcu-
lations are considered “excellent” measures [19]. For the
assessment of concurrent validity (hypothesis testing) it is
up to the reviewer to assess if the method is “appropriate”
and therefore scores “excellent.” For the assessment of
measurement error (agreement), Standard Error of Mea-
surement (SEM), Smallest Detectable Change (SDC), and
Limits of Agreement (LoA) calculated using the Bland-
Altman method are accepted as “excellent.” According to
the COSMIN a sample size of less than 30 participants is
considered “poor,” 30–49 participants is considered “fair,”
50–99 participants is considered “good,” and 100 or more
participants is considered “excellent” [19]. Authors were
contactedtoseeiftheyhadusedanypowercalculationswhen
determining their sample size.
Qualitycriteriafortheclinimetricpropertiesofmeasures
were proposed to give a framework to help distinguish
between the quality of the studies and the performance of
the measurement tools [20]. Agreement, criterion validity,
and construct validity were therefore scored as good (+),
indeterminate (unable to assess: u/a), or poor (−)[ 20].
Criterion validity was considered “good” if correlation with
gold standard was ≥0.70, sensitivity and speciﬁcity ≥0.70,
and area under receiver operating characteristic curve ≥0.70
[20]. Construct validity was considered “good” if 75% of
the results were in accordance with the hypothesis [20].
Measurement error is considered “good” if the SDC or the
LoA are smaller than the minimal important change or if
“authors provide convincing arguments that the agreement
is acceptable” in a sample size of at least 50 participants
[20]. Studies that used a “poor” statistical method scored
“indeterminate” for performance of clinimetric properties.
The assessment of clinimetric properties of HR-PRO
questionnaires might be of a diﬀerent nature to those
assessing activity measures due to the availability of gold
standards, something which is not readily available for HR-
PROs as these are usually questionnaires regarding patient
outcomes such as pain and quality of life [21]. The statistical
methods and performance of clinimetric properties were
therefore scored according to the COSMIN but were also
discussed further, and a diﬀerent score was given if authors
presented a convincing argument that the measure was
acceptable.
2.6. Clinical Utility. The clinical utility of measures of HPA
was assessed in terms of the need for individual calibration
of the equipment, the interpretability of the data output, and
the need for software analysis, cost of equipment, and any
required software. The feasibility of the equipment for using
childrenagedlessthansixyearswithamotordisabilityinfree
living situations was also considered (size, weight, number of
sensors, place worn, ease of correct placement, and battery
life). The richness of data was also assessed in terms of what
aspects of HPA (frequency, duration, intensity, mode, and
energy expenditure) it was able to assess in children with a
motor disability.
2.7. Overall Level of Evidence. T h eo v e r a l ll e v e lo fe v i d e n c e
for the clinimetric properties of measures of HPA in
young children with motor disabilities was determined as
a whole by assessing the methodological quality of study
design and statistical methods used in the assessment of4 International Journal of Pediatrics
1771 abstracts yielded
1st screening of titles and
abstracts
1567 abstracts excluded
3rd screening of 31 full papers
and 2 abstracts from conference
proceedings
27 papers and 1 abstract
from conference
proceeding
2nd screening of 204 titles and
abstracts
171 abstracts excluded
Identiﬁed measures in children
with motor disabilities:
Activity monitoring pod
Minimod
StepWatch
Intelligent device for
energy expenditure and
activity (IDEEA)
StepWatch
•
￿
￿
￿
￿
￿
Minimod
Targeted search for
measures in typically
developing children (3
papers) :
4 papers and 1abstract from
conference proceeding included
Figure 1: Flow diagram for search strategy.
HPA measures using the “worst score counts” algorithm,
agreement between studies on the quality of clinimetric
properties of these HPA measures,andthe number of studies
available for each HPA measure.
3. Results
Descriptionoftheresultsofthesearchstrategycanbeseenin
Figure 1. The initial search yielded 1771 titles, and abstracts
after duplicates were deleted. The initial screening by titles
and abstracts excluded 1567 titles, and the second screening
excluded a further 171 papers. Thirty-one full papers and
two abstracts from conference proceedings were further
r e v i e w e d .F o u rp a p e r sa n do n ea b s t r a c tf r o mc o n f e r e n c e
proceedingsontheclinimetricpropertiesoffourmeasuresof
HPAinchildrenwithmotordisabilitieswereidentiﬁedwhich
included children aged less than six years in their sample.
None of the studies focused exclusively on children aged less
than six years, which led to the inclusion of studies with a
wide age range (4–18 years).
The characteristics of the studies are detailed in Table 1.
Evidence of clinimetric properties was found for three
accelerometer-based activity monitors [22–26]a n do n e
pedometer using inertial sensors [23] .Ap a p e rb yK u oe ta l .
[23]andanabstractfromconferenceproceedingsbyBrandes
et al. [22] were identiﬁed for the Minimod pedometer
(DynaPort McRoberts, Hague, Netherlands). The Activity
Monitoring Pod-331 pedometer which uses inertial sensors
(AMP; Dynastream Innovations, Alberta, Canada) was also
assessed in the paper by Kuo et al. [23]. Papers by Stevens
et al. [24] and McDonald et al. [25] were identiﬁed for the
StepWatch pedometer (Orthocare Innovations, WA, USA).
A paper by Aviram et al. [26] assessed the Intelligent Device
for Energy Expenditure and Activity (IDEEA; Minisun,
CA, USA). Only McDonald et al. [25] assessed children
with Duchenne muscular dystrophy (DMD); others assessed
children with CP who were able to walk with or without
aids (Gross Motor Function Classiﬁcation System levels I–
III)[22–24,26].Noneofthestudysamplesincludedchildren
who did not walk as their main means of locomotion.
All of the studies of children with motor disabilities
included TDC as a reference group [22–26]. Sample sizes
ranged from 17 to 27 children with motor disabilities and
7–27 in the TDC reference group. All authors were contacted
to clarify the proportion of children in their study who were
under the age of six. The study by Brandes et al. [22]o n
the use of the Minimod included one child (5%) with CP
aged ﬁve years old and four children (20%) in the TDC
sample aged three to ﬁve years. The study by Aviram et al.
[26] included nine children (43%) aged four to ﬁve years
with three children in each GMFCS category (I–III). The
authors did not supply the number of TDC aged ﬁve years,
but the youngest of the seven children in the TDC group
w a s5y e a r sa n d8m o n t h so l d[ 26]. In the study by Kuo et
al. [23] it was estimated that a maximum of two children
in the CP (11%) and TDC (10%) group were less than
six years old, although authors were not able to readily
access information to conﬁrm this. It is not known how
many children were under the age of six in the study by
Stevens et al. [24] and McDonald et al. [25]. The targeted
search for studies reporting on the clinimetric properties of
the identiﬁed measures in young TDC identiﬁed a further
three studies assessing the Minimod [27] and the StepWatch
[28, 29]. The sample size in the three studies ranged from
20 to 162 children, and ages ranged from 2 to 16 years. The
StepWatch study by Bjornson et al. [28] reported results for
two-to-three-year olds (n = 60) and four-to-ﬁve-year olds
(n = 62) TDC separately. The StepWatch study by Song
et al. [29] used two age bands (5–7 years and 9–11 years)
with ten children in each group, but the number of ﬁve year
old children in the youngest group was not speciﬁed by the
authors upon request. In the paper by Brandes et al. [27],
authors report on the same sample of TDC (n = 20, four
children ≤6.0 years) as in the previously mentioned abstract
from conference proceedings. The full paper and abstract
from conference proceedings will be rated as one paper.
3.1. Rating of Study Designs. Description of the study design
of included papers is outlined in Table 1. None of the authors
using manual step count as a criterion method reported on
the accuracy of the manual step count (intra- or interrater
agreement). Although it can be assumed that it is a gold
standard, no evidence has been provided, and therefore the
maximum attainable score for all studies according to the
COSMIN checklist was “good” [19]. The study by Brandes
et al. [22, 27] assessed the criterion validity of the Minimod
inchildrenwithCPandTDCcomparedtomanuallycounted
steps and meters walked was rated “good” for study design.
Authors report complete information in regarding testInternational Journal of Pediatrics 5
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protocol (monitor settings, placement, data output, average
steps needed for length walked, and range of steps across
group) but only tests of continuous walking that may not
adequately reﬂect free-living walking activity. The study by
Kuo et al. [23] on the criterion validity of the Minimod and
AMP compared to manually counted steps and measured
meters walked was rated “good” on this construct. Authors
report complete information on test protocol and use of a
variety of structured activities: continuous walking; activity
lap walking which includes walking, stopping, completing a
simple task, and walking again; stair ascent and descent.
The studies by Stevens et al. in children with CP [24],
McDonald et al. in children with DMD [30], and Song et
al. in TDC [29] all assessed the criterion validity of the
StepWatch against manual step count and scored “poor”
for study design due to providing no information on parts
of their study protocol (number of steps, range of steps
needed, and length walked). This does not necessarily mean
the design was genuinely poor, but the lack of reporting does
not enable assessment on applicability in measuring habitual
walking activity and has implications for the interpretation
of any reported statistics. The study by Bjornson et al. [28]
assessed the StepWatch for criterion validity in TDC against
manual step counts and was rated “good” for study design
as they report a complete test protocol, though only assessed
performance during continuous walking.
The study by Aviram et al. [26] assessed the criterion
validity of energy expenditure (EE) measured by the IDEEA
compared to the gold standard of indirect calorimetry using
the Cosmed (K4b2, Rome, Italy) which measured oxygen
consumption (VO2) in ﬁve-second epochs. Authors reported
complete study protocol information and assessed a range
of everyday activities in addition to comfortable and fast
treadmill walking and stair climbing. The study scored
“good” for study design due to not providing any evidence
of the Cosmed being a gold standard measurement although
it can be assumed adequate [19]. Authors discuss possible
limitations of the use of the Cosmed, which include a poor
ﬁtting mask, which may lead to inaccurate measurement.
This study also assessed the test-retest reliability of the
IDEEA and received an “excellent” rating for study design in
the assessment of this construct.
The StepWatch study in children with DMD [25]u s e da
heart rate monitor to assess its concurrent validity over four
days of wear. This study was rated “fair” for study design in
the assessment of this construct as an ap r i o r ihypothesis of
the relationship between the StepWatch and heart rate was
not stated, but it was possible to deduce what was expected
[19].
3.2. Rating of Statistical Methods and Clinimetric Performance
of Measures. The clinimetric properties measured for all the
studies reviewed are outlined in Table 2. All studies apart
from the study by Bjornson et al. [28]h a das a m p l es i z eo f
less than 30 children which constitutes a “poor” score on the
COSMIN checklist, while the sample size of 60–62 children
in each age group found in the Bjornson et al. study [28]
receives “good” rating on this item. Three of the four authors
who replied had not used a power calculation to determine
sample size [22, 23, 26, 27], and one author stated in their
reply that the recruitment of 60 children in each group
(30 boys and 30 girls) was chosen as it was expected this
would “increase the likelihood of approximating a normal
distribution” [28]. It is not known if Stevens et al. [24]
and McDonald et al. [25] used any power calculations to
determine their sample size. As the COSMIN works on a
“worst score counts” algorithm, the highest score possible
for all but one study is therefore “poor,” but as several
studiesreportsigniﬁcantresults,furtherdiscussionaboutthe
clinimetric performance of measures is warranted.
Percent agreement was used to assess the criterion
validity of the Minimod in children with CP and TDC
by Brandes et al. [22, 27], and the use of this method
leads to a “poor” rating for statistical methods according
to the COSMIN as it comes under “any other statistical
method” [19]. Percent agreement is a relative measure and
therefore depends on reporting of the absolute values for
meaningful interpretation. Authors present rich information
such as the average steps needed to walk the 20-meter track
(CP children) and 160-meter track (TDC) and range of
steps taken [22, 27]. It is therefore possible to see that the
measurement error is small. Children with CP (n = 19)
walked an average of 79.8 steps (min: 57; max: 126), and on
average the Minimod over- or underestimated by one step
(agreement = 98.7%; range: 94.1 to 101.8%) [22, 27]. TDC
(n = 20) walked an average of 273.7 steps (min: 207; max:
377), and on average the Minimod over or underestimated
by one step (agreement = 99.6%; range: 98.5 to 101.5%)
[22, 27]. Children with CP walked only one-third of the
steps TDC walked, and a higher likelihood that agreement
occurred by chance exists. Due to good reporting of study
protocol and results, percent agreement was considered an
“excellent” statistical method. The Minimod showed “good”
accuracy and precision for the measurement of continuous
walking. A limitation of this study was the assessment of
continuous walking only, and therefore the criterion validity
for measuring HPA is “indeterminate.”
The issue of use of percent agreement arises in two other
studies assessing the StepWatch in TDC. Percent agreement
is used by Song et al. [29] who compare steps measured and
manual step count. They found a measurement error of 3 ±
1% [29] but did not report how long children walked or how
many steps they took which does not allow the assessment of
absolute measurement error or the likelihood that the error
was low by chance. For this same study, a Pearson correlation
coeﬃcient has been reported in a separate paper [31]w h i c h
by COSMIN standards was an “excellent” statistical method,
but the lack of information about the study protocol still
applies as correlation could have been estimated based on
a small number of steps. The use of percent agreement
and Pearson correlation coeﬃcient in this study receives a
“poor” rating, and evidence of criterion validity based on
this study was “indeterminate.” Percent agreement was also
used in the study by Bjornson et al. [28] but total steps taken
are reported as ≥100 steps, and therefore it is possible to
assess the absolute value of agreement in step count for two-
three-year olds (99.2 ± 4.6%) and 4-5-year olds (100.0 ±
4.4%). In this study, the use of percent agreement thereforeInternational Journal of Pediatrics 7
rates as “excellent,” and the evidence of criterion validity for
continuous walking is “good” which is further strengthened
by the large sample size. Criterion validity for measurement
of HPA cannot be determined based on this study. A further
two studies assess the use of the StepWatch in children with
CP [24]a n dD M D[ 25] but do not report any statistical
methods or results which was rated “poor,” and criterion
validity for these populations was therefore “indeterminate.”
Bland-Altman plots [32]a n dp e r c e n to fa c t i v i t yl a p s
which were detected were used to assess criterion validity
in the combined study of the Minimod and AMP by Kuo
et al. [23] and due to this would have scored “poor” on
the COSMIN checklist [19]. The lack of a speciﬁc index to
summarise the degree of agreement is a limitation of the
Bland-Altman technique, and inferences about the estimate
cannot be performed [33]. A strength of the Bland-Altman
technique is that it produces a meaningful graph and
computes the conﬁdence limits from the paired diﬀerences
between the criterion method (manual step count or meters
walked) and the same variables measured by the Minimod
[33]. This provides us with the ability to assess both accuracy
and precision of measures and allows a comparison between
groups and therefore still allows a thorough assessment
of the agreement between methods and can be rated as
an “excellent” statistical method. The Minimod performed
well in continuous walking trials compared to measured
length and direct observation of steps (mean diﬀerence =
−0.4m/−0.4 steps, 95% limits of agreement = −4.7 to
4m/−4.1 to 3.3 steps) but showed a larger random error
for activity lap walking (mean diﬀ. = −2.3m/−0.4 steps,
95% LoA = −27.9 to 23.3m/−87.8 to 10.4 steps) [23].
The Minimod only detected walking activity in 19–37%
of stair walking trials (ascent/descent) [23]. In TDC, the
Minimod performed well for continuous walking trials and
poor in structured activity laps (see Table 2); however it
performed better for detecting stair walking (84%) [23].
TheAMPshowedgreaterunderestimationandrandomerror
in continuous walking trials (mean diﬀ. = −4.8m/−3.5
steps, 95% LoA = −20.1 to 10.5m/−1 6 . 9t o1 0s t e p s )
which increased with increasing distance walked [23]. The
AMP performed better than the Minimod in the structured
activity lap walking trials, but still showed considerable bias
diﬀerence and large random error in this trial (mean diﬀ. =
−3.6m/−11.2 steps, 95% LoA = −19.2 to 12.0m/−40 to
17.7 steps), however detected more of the stair climbing
trials (85%) [23]. Results were similar for TDC (see Table 2)
[23]. Due to the lack of an index, a speciﬁc cut-oﬀ for what
classiﬁes as a “good” result cannot be set; however the results
indicatethattheMinimodhas“good”accuracyandprecision
for continuous walking. When it comes to more free-living
type activities such as the structured walking trial and stair
walking, the performance of the Minimod is “poor.” The
AMP showed “poor” precision and accuracy in both walking
trials, however detected more stair trials. As the focus of
this paper is the ability to measure free-living activities, both
monitors score “poor” for evidence of criterion validity for
measuring HPA.
AP e a r s o nc o r r e l a t i o nc o e ﬃcient was used to assess
agreement between the EE measured by the IDEEA and the
criterion method of indirect calorimetry using the Cosmed
[26]. A Pearson correlation is considered an “excellent” sta-
tistical method by the COSMIN [19]. For the daily activities
trial, total energy expenditure was used as the outcome mea-
sure. For comfortable and fast treadmill walking and stair
climbing trials, energy expenditure rate (kcal/minute) was
used. For children with CP and TDC the correlation between
measurement outputs was “good” by COSMIN standards
during all activities (CP: r = 0.70–0.88; TDC: r = 0.74–
0.97, P ≤ 0.05) [26]. A limitation of the Pearson correlation
coeﬃcient is that it only measures precision not accuracy
and is therefore not a true measure of agreement [33]. This
is demonstrated by the authors of this paper as the IDEEA
signiﬁcantly overestimated energy expenditure during the
seriesofeverydayactivitiesandduringcomfortabletreadmill
walking both in children with CP and TDC, and during fast
treadmill walking in TDC (paired t-test, P<0.01) [26].
DuringfasttreadmillwalkinginchildrenwithCPandduring
stair walking in both groups, measured energy expenditure
did not diﬀer signiﬁcantly between methods (paired t-test,
P>0.01) [26]. A limitation of the t-test is that it will only
show a signiﬁcant diﬀerence if there is a systematic constant
diﬀerence between two values, not if there is a systematic
proportional diﬀerence as the paired diﬀerence will end up
c l o s et oz e r o[ 34]. A Bland-Altman plot or a regression
analysis would provide a better identiﬁcation of the nature of
anysystematicdiﬀerencesintheEEestimationoftheIDEEA.
The present energy expenditure calculations used in the
IDEEA software do not accurately assess energy expenditure,
and the clinimetric properties of the IDEEA are therefore
considered “poor.” Authors suggest the good correlation
between the IDEEA and the Cosmed indicates it can be used
as a clinical follow-up tool for quantitative evaluation of
eﬃcacy of treatment interventions. As the IDEEA appears
to perform better at higher intensities, systematic diﬀerences
may exist which may lead to inaccurate conclusions. The
reliability of EE measurement by the IDEEA was assessed in
children with CP (n = 12) [26] using a Pearson’s correlation
coeﬃcient and a paired t-test. Authors aimed to assess
“agreement” between repeated measures as discussed in de
V e te ta l .[ 35]. This study therefore scored “poor” for choice
of statistical method as measures can signiﬁcantly correlate
despite being signiﬁcantly diﬀerent, and the inability of a t-
test to detect systematicproportional diﬀerencesas discussed
previously still applies [33, 34]. Agreement between repeated
measuresofEEusingtheIDEEAistherefore“indeterminate”
based on this study.
Authors of the StepWatch study in children with DMD
[25]usedaheartratemonitortoassessitsconcurrentvalidity
and received a “good” rating for statistical method as they
used a Pearson correlation coeﬃcient but did not report
standarddeviation.Evidenceofconcurrentvaliditywasrated
poor as r<0.70 (CP: r = 0.295; TDC: r = 0.477; P<0.05).
3.3. Clinical Utility. Clinical utility was assessed for the
four identiﬁed measures and is summarised in Table 2.
The Minimod and StepWatch require individual calibration
and software for analysis. The StepWatch is expensive (cost
not available for Minimod). The rich data collected by the8 International Journal of Pediatrics
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Table 3: Evidence of criterion validity.
Measure Study Study design Statistical method Criterion validity for HPA
Minimod Kuo ++ +++ −
Brandes ++ +++ u/a
AMP Kuo ++ +++ −
IDEEA Aviram ++ +++ −
StepWatch Stevens − u/a u/a
McDonald − u/a u/a
Song (TDC only) −− u/a
Bjornson (TDC only) ++ +++ u/a
IDEEA: Intelligent Device for Energy Expenditure and Activity; TDC: typically developing children; (+++): excellent; (++): good; (+): fair, (−): poor, (u/a):
unable to assess/indeterminate.
StepWatch and Minimod allows measurement of intensity,
frequency, and duration of walking activity. The units are
both small and unobtrusive and have battery lives of seven
days for the Minimod and up to six weeks for the StepWatch,
depending on settings. This makes them both feasible tools
forthemeasurementofhabitualwalkingactivity.Intheevent
that data collection is delayed once the device is provided to
the child’s parents, having a battery life of more than seven
days, and therefore not requiring recharging is a strength
of the StepWatch as there is less likelihood of loss of data.
The Minimod is worn around the waist centred at the lower
lumbar spine, while the StepWatch is worn on the ankle in
as m a l lc u ﬀ. Consistency of placement for repeated and all-
day wear may be easier to achieve with an ankle placement
which would reduce measurement error due to inconsistent
placement. Both pedometers were considered to have good
clinical utility. The AMP is small, worn around the ankle,
does not require calibration or software analysis, and has a
good battery life; however it only measures total step count
or meters walked per wear period. The AMP was considered
to have good clinical utility. The IDEEA consists of a data
recorderwornonthewaistwith5individualsensorsattached
to the chest, thighs, and under each foot connected by wires
to allow measurement of postures and energy expenditure,
and it only has a battery life of 60 hours. Both of these factors
limittheIDEEAsutilityinthemeasurementofHPAinyoung
children.
3.4. Level of Evidence. A summary of the quality of evidence
forcriterionvalidityisprovidedinTable3.Twostudiesassess
theMinimodinchildrenwithCPandTDCinsampleswhich
include children under the age of six. Both studies were
rated “good” for study design and “excellent” for statistical
method. They provided “good” evidence of the ability of the
Minimod to accurately measure continuous walking. One of
these studies [23] also used free-living type activities, and
theMinimoddisplayed“poor”accuracyandprecisioninthis
setting. The AMP was assessed in one study of “good” study
design quality which used an “excellent” statistical method,
though displayed “poor” accuracy and precision in both
continuous walking and free-living type activities.
Four studies assess the StepWatch in samples which
included children under the age of six. Reporting of study
protocol and statistical method was “poor” in three of
these studies. The fourth study was of “good” quality and
used an “excellent” statistical method. It provided “good”
evidence of the ability of the StepWatch to accurately
measure continuous walking in TDC. The ability of the
StepWatch to accurately measure free-living activities cannot
be determined based on this study. The ability of the IDEEA
to measure EE was assessed in one study of “good” study
design quality which used an “excellent” statistical method;
however the IDEEA displayed “poor” accuracy and precision
in both free-living type activities and continuous walking
trials.
4. Discussion
This paper has systematically reviewed the clinimetric
properties (validity, reliability, and clinical utility) of four
measures of HPA in children with a motor disability which
included children aged less than six years. A precise and
accurate measurement of the daily physical activity levels in
this population will allow researchers to investigate the dose-
response relationship between HPA and health outcomes. It
will also allow the assessment of the eﬃcacy of interventions
aimedatincreasingHPAintermsofestablishingthedoseand
distribution of treatment necessary to achieve worthwhile
results in the long term. For clinicians, an accessible, precise,
and accurate measurement tool would allow the identiﬁca-
tion of children with low levels of HPA and in turn the
assessment of the eﬀectiveness of prescribed interventions.
Promising measures of HPA have been assessed in young
children with motor disabilities, and the methodological
quality of the papers was good to poor for study design
and excellent to poor for statistical methods. A limitation
of the ﬁndings of this paper is that only two studies
of overall “good” methodological quality assessed children
while undertaking free-living type activities. Under these
conditions, both activity monitors displayed poor accuracy
and precision [23, 26]. Two activity monitors displayed
“good” accuracy during continuous walking [23, 28]. This
relates more to the ICF deﬁnition of walking “capacity”
rather than habitual walking activity (i.e., how many steps
does a child need to walk a set distance in an ideal envi-
ronment compared to how many steps do they take during
the day in a variety of settings and intensities). Another
limitation is that studies included in this paper assessed10 International Journal of Pediatrics
childrenacrossawideagerange(4–18years),withnostudies
ofchildrenwithmotordisabilitiesexclusivelyfocusingonthe
under six-year age group which limits this review’s ability
to make speciﬁc recommendations for this age group. The
proportion ofchildrenagedlessthansix inthestudysamples
ranged from 5 to 43% for the studies which provided a
breakdown of their sample [22, 23, 26, 27]. The use of
the COSMIN checklist for the assessment of methodological
quality together with quality rating criteria of measurement
properties is also a possible limitation. The COSMIN check-
list was developed for assessing HR-PROs and does not have
established psychometric properties in assessing objective
physical activity measurement tools, and the quality rating
criteria were not developed based on consensus. This issue
was minimised by being guided by a systematic review of
activitymonitorsinTDCfortheassessmentofthesomewhat
ambiguous “ﬂaws in design or methods” item used in the
COSMIN (Box H, item 5) [19] and by providing an in-depth
appraisal of the statistical methods.
The current Australian physical activity guidelines rec-
ommend children aged from 1 to 5 years engage in active
play for at least three hours per day without speciﬁc intensity
recommendations [2]. This recognises the sporadic and
intermittent nature of young children’s activity patterns and
places demands on the measurement tools used to assess
HPA in this population. Firstly they have to be able to
record activity as a measure of time, and secondly they
need to accurately recognise “active play” behaviours. The
accelerometer-based pedometers StepWatch and Minimod
have the ability to collect the most complete information
on habitual walking activity as they record steps within an
epoch of time which can be downloaded onto a computer
to visualise an activity pattern. They allow the assessment
of intensity (e.g., steps/min), frequency (e.g., number of
walking bouts), and duration (e.g., length of walking bouts).
The validation protocols of the included studies primarily
used structured walking activities which may not accurately
represent the way young children move in active play, and
therefore it cannot be assumed activity monitors that do well
in continuous walking trials would have done equally well
had the children’s steps been counted during free-living play.
This was demonstrated in the assessment of the Minimod
by Kuo et al. [23]. In typically developing children, activity
monitors are usually validated by direct observation of free
play to circumvent this issue, and validation studies typically
use a narrower age range to control for diﬀerences in motor
skills [36, 37].
Children with a motor disability may not be able to walk
but instead use a range of other methods of ambulation
such as crawling, cruising, rolling, bottom shuﬄing, walking
aids, or wheelchairs. Those who are able to walk may have
diﬀerent gait patterns than typically developing children
[14]. This could explain why the accelerometer Minimod,
which relies on recognising gait patterns to count steps,
had a lower rate of activity detection in children with CP
(19–97%) than in typically developing children (84–100%)
[23].Othermeasurementtoolssuchasaccelerometers,which
report raw activity counts per epoch of time, bypass this
limitation but are yet to be validated in young children with
a motor disability. A systematic review of measures of HPA
in TDC preschoolers identiﬁed the ActiGraph (Shalimar, FL,
USA) accelerometer as having the best clinimetric properties
in this population. Similarly, the systematic review of HPA
measurements in adolescents with CP by Clanchy et al. [16]
identiﬁed accelerometers as the most comprehensive mea-
sure of HPA patterns despite the limited evidence available,
and the ActiGraph has since been validated in adolescents
with CP [38, 39]. Studies of doubly labelled water [40, 41],
the Compendium for Physical Activity Questionnaires [3]
andActiGraphininfantsatriskofneurodevelopmentaldelay
[42], did not meet inclusion criteria as their clinimetric
properties for the measurement of HPA in children with
motor disabilities aged less than six years had not been
assessed.
5. Conclusion
This systematic review identiﬁed four measures of HPA
with evidence of clinimetric properties in study samples
which included children aged less than six with motor
disabilities. Only a very small number of studies assessing
activity monitors in this population are available, and none
of the studies focus exclusively on children aged less than
six years. The pedometers StepWatch and Minimod are the
most comprehensive measures of habitual walking activity
utilised in the current literature. While both demonstrate
good accuracy for step count during continuous walking,
only the Minimod has been tested during conditions which
included walking trials other than continuous walking,
and it performed poorly during these conditions. It is
possible the ankle placement of the StepWatch would allow
a more accurate assessment of free-living walking activities
in children with motor disabilities but this is yet to be
demonstrated. Pedometers are only suitable as an estimate of
HPA for children with high functional capacity as children’s
HPA patterns are likely to consist of a progressively smaller
proportion of walking as the severity of their impairment
increases. In the most severely impaired children walking
activity is completely nonexistent. Further research is needed
to ascertain the clinimetric properties of activity monitors
available for measuring HPA in young children with motor
disabilities, and testing protocols should include a range of
activities and ideally direct observation of free play. This will
enable an understanding of the HPA patterns of children
with motor disabilities across the spectrum of functional
capacity for clinicians and researchers alike.
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